- Country: Ukraine
- Summary: Аlbumin, Rivaroxaban, Rivaroxaban
- UAT Ref No: 133372324
- Deadline: 13 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 1011300
- Notice Type: Tender
- Document Ref. No.: UA-2026-01-07-005365-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Name Classifier and its corresponding code Quantity/Units of measurement Place of delivery Date of delivery Name Albumin, solution for infusions, 10%, 100 ml each, Rivoroxaban film-coated tablets, 10 mg each, Rivoroxaban film-coated tablets shell, 2.5 mg each
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINАlbumin, Rivaroxaban, Rivaroxaban - Ukraine Tender
The MUNICIPAL ENTERPRISE "KHMELNYTSK CITY HOSPITAL" OF THE KHMELNYTSK CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Аlbumin, Rivaroxaban, Rivaroxaban. This tender is published on UkraineTenders under UAT Ref No: 133372324 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-13.
The estimated tender value is UAH 1011300, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
